Neuralink, Elon Musk's company, received FDA approval to expedite its vision technology, 'Blindsight,' through the regulatory process.
Science Corp., founded by Neuralink's former president, announced successful preliminary results from a clinical trial. The trial showed some vision restoration in patients with age-related macular degeneration.
Both companies aim to address widespread vision problems like macular degeneration using advanced brain-computer interface technology.
Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that could treat patients with severe vision loss, pursuing sci-fi-like solutions to widespread maladies like macular degeneration.
In September, Neuralink received the Food and Drug Administration’s blessing to fast-track its vision technology, called Blindsight, through the regulatory process. And last month, Science, the brain-machine interface startup run by former Neuralink President Max Hodak, announced the results of a clinical trial showing some restored vision to patients suffering from age-related macular degeneration.
If you often open multiple tabs and struggle to keep track of them, Tabs Reminder is the solution you need. Tabs Reminder lets you set reminders for tabs so you can close them and get notified about them later. Never lose track of important tabs again with Tabs Reminder!
Try our Chrome extension today!
Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more